Combination therapy with metronidazole and azathioprine reduces severe postoperative recurrence of Crohn's disease: A double-blind controlled randomized trial

被引：0
|
作者：
D'hatens, Geert R.
Noman, Maja
Van Assche, Gen A.
Van Olmen, Gust
Aerden, Isolde
Vermeire, Severine
Rutgeerts, Paul J.
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A52 / A52
页数：1
相关论文
共 50 条
  • [1] Addition of Metronidazole to Azathioprine for the Prevention of Postoperative Recurrence of Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    Manosa, Miriam
    Cabre, Eduard
    Bernal, Isabel
    Esteve, Maria
    Garcia-Planella, Esther
    Ricart, Elena
    Penalva, Mireia
    Cortes, Xavier
    Boix, Jaume
    Pinol, Marta
    Gassull, Miquel A.
    Domenech, Eugeni
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (09) : 1889 - 1895
  • [2] Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: A controlled randomized trial
    D'Haens, Geert R.
    Vermeire, Severine
    Van Assche, Gert
    Noman, Maja
    Aerden, Isolde
    Van Olmew, Gust
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2008, 135 (04) : 1123 - 1129
  • [3] Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: A randomized, double-blind, placebo-controlled trial
    Rutgeerts, P
    Van Assche, G
    Vermeire, S
    D'Haens, G
    Baert, F
    Noman, M
    Aerden, I
    De Hertogh, G
    Geboes, K
    Hiele, M
    D'Hoore, A
    Penninckx, F
    GASTROENTEROLOGY, 2005, 128 (04) : 856 - 861
  • [4] Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial
    Orlando, A.
    Mocciaro, F.
    Ventimiglia, M.
    Renna, S.
    Rispo, A.
    Scribano, M. L.
    Testa, A.
    Aratari, A.
    Bossa, F.
    Angelucci, E.
    Onali, S.
    Cappello, M.
    Giunta, M.
    Scimeca, D.
    Macaluso, F.
    Castiglione, F.
    Papi, C.
    Annese, V
    Biancone, L.
    Kohn, A.
    Di Mitri, R.
    Cottone, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (21) : 11356 - 11364
  • [5] A double-blind, double-dummy, randomized, controlled, multicenter trial on the efficacy and safety of azathioprine vs mesalamine for prevention of clinical relapses in Crohn's disease patients with postoperative moderate or severe endoscopic recurrence
    Reinisch, Walter
    Angelberger, Sieglinde
    Petritsch, Wolfgang
    Herrlinger, Klaus
    Shonova, Olga
    Lukas, Milan
    Bar-Meir, Simon
    Schwab, Matthias
    Greinwald, Roland
    Mueller, Ralph
    Stange, Eduard
    GASTROENTEROLOGY, 2008, 134 (04) : A70 - A70
  • [6] SONIC: A randomized, double-blind, controlled trial comparing Infliximab and Infliximab plus Azathioprine to Azathioprine in patients with Crohn's Disease naive to immunomodulators and biologic therapy
    Sandborn, W.
    Rutgeerts, P.
    Reinisch, W.
    Mantzaris, G.
    Kornbluth, A.
    Rachmilewitz, D.
    Lichtiger, S.
    D'Haens, G.
    van der Woude, C.
    Diamond, R.
    Broussard, D.
    Hegedus, R.
    Colombel, J.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S1 - S1
  • [7] Sonic: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to Immunomodulators and biologic therapy
    Sandborn, W.
    Rutgeerts, P.
    Reinisch, W.
    Kornbluth, A.
    Lichtiger, S.
    D'Haens, G.
    van der Woude, C.
    Diamond, R.
    Broussard, D.
    Colombel, J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S436 - S436
  • [8] Onercept for moderate-to-severe Crohn's disease: A randomized, double-blind, placebo-controlled trial
    Rutgeerts, Paul
    Sandborn, William J.
    Fedorak, Richard N.
    Rachmilewitz, Daniel
    Tarabar, Dino
    Gibson, Peter
    Nielsen, Ole Haagen
    Wild, Gary
    Schreiber, Stefan
    Rossi, Claudia Pena
    Zignani, Monia
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (07) : 888 - 893
  • [9] Ciprofloxacin for the Prevention of Postoperative Recurrence in Patients with Crohn's Disease: A Randomized, Double-blind, Placebo-controlled Pilot Study
    Herfarth, Hans H.
    Katz, Jeffry A.
    Hanauer, Stephen B.
    Sandborn, William J.
    Loftus, Edward V., Jr.
    Sands, Bruce E.
    Galanko, Joseph A.
    Walkup, Dolly
    Isaacs, Kim L.
    Martin, Christopher F.
    Sandler, Robert S.
    Sartor, Ryan B.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (05) : 1073 - 1079
  • [10] Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial
    D'Haens, Geert
    Taxonera, Carlos
    Lopez-Sanroman, Antonio
    Nos, Pilar
    Danese, Silvio
    Armuzzi, Alessandro
    Roblin, Xavier
    Peyrin-Biroulet, Laurent
    West, Rachel
    Mares, Wout G. N.
    Duijvestein, Marjolijn
    Gecse, Krisztina B.
    Feagan, Brian G.
    Zou, Guangyong
    Hulshoff, Melanie S.
    Mookhoek, Aart
    Oldenburg, Lotte
    Bouhnik, Yoram
    Laharie, David
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2025, 10 (01): : 26 - 33
12345